Workflow
Nashville-based Healthcare Consulting Group, FKP Advisors, joins the Board of Directors of Healthcare Integrated Technologies Inc.
GlobeNewswire· 2025-04-22 13:15
Knoxville, TN, April 22, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, is proud to announce the appointment of FKP Advisors LLC, a Nashville-based healthcare consulting group, to its Board of Directors. FKP Advisors LLC board seat will be on a rotational basis with its founding partners: Larry Kloess III serving in the first year, followed by Jim Fitzgerald in the second year, and Ben Pope in the third Year. M ...
Freeze Tag Launches TownTrek App, Powered by Eventzee Technology, to Promote Community Exploration
GlobeNewswire· 2025-04-22 13:15
Tustin, CA, April 22, 2025 (GLOBE NEWSWIRE) -- Freeze Tag (OTC: FRZT), a leading creator of location-based mobile social games, is excited to announce the launch of TownTrek, an innovative application powered by Eventzee’s scavenger hunt technology. TownTrek offers users an engaging way to explore their communities through interactive challenges and activities.​ “We’re thrilled to introduce TownTrek, leveraging Eventzee’s robust platform to create immersive local experiences,” said Craig Holland, CEO of Fre ...
Tejon Ranch Co. Files Investor Presentation Highlighting Strategy for Significant Long-Term Value Creation
GlobeNewswire· 2025-04-22 13:15
Tejon’s Board Continues to Take Decisive Strategic Steps to Drive the Company’s Growth at Tejon Ranch Commerce Center and is Uniquely Positioned to Advance the Value of its Master-Planned Communities Urges Shareholders to Vote “FOR” Only Tejon’s Highly Qualified Director Nominees on the Company’s WHITE Proxy Card TODAY TEJON RANCH, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Tejon Ranch Co. (NYSE:TRC), (“Tejon” or the “Company”), a diversified real estate development and agribusiness company, today filed an ...
Prosafe SE: Operational update – March 2025
GlobeNewswire· 2025-04-22 13:10
22 April - Fleet utilisation for March 2025 was 52 per cent. Safe Zephyrus operated at full capacity during March, achieving 100 per commercial uptime. Safe Notos and Safe Eurus, both had 99 per cent commercial uptime in March. Safe Concordia operated at full capacity on the days she was in operation. The vessel was transferred to the new owner on March 13, 2025. Safe Caledonia has commenced reactivation activities in Scapa Flow, UK, and will mobilise to the Captain Field, UK, by 01 June 2025. Safe Bor ...
Primech AI Showcases HYTRON Cleaning Technology at Global Innovation Summit 2025 in Germany
GlobeNewswire· 2025-04-22 13:08
Core Insights - Primech AI participated in the Global Innovation Summit 2025, showcasing its AI-powered autonomous bathroom cleaning robot, HYTRON, to an international audience [1][2][3] - The event provided a platform for Primech AI to connect with potential partners and customers across various sectors, enhancing its international expansion strategy [3][5][6] Company Overview - Primech AI is a subsidiary of Primech Holdings Limited, focusing on innovative robotics solutions [1][9] - The company aims to revolutionize the robotics industry with advanced technology and sustainable practices [9][10] Product Highlights - HYTRON features advanced AI capabilities, 3D-cleaning functionality, and utilizes electrolyzed water for enhanced sanitation [3][4] - The performance of HYTRON is significantly enhanced by the integration of NVIDIA Jetson Orin Nano Super, which improves real-time data processing and autonomy [4] Market Engagement - During the summit, Primech AI engaged with various sectors, including commercial property management, healthcare, hospitality, and public transportation, to explore the implementation of its autonomous cleaning solutions [5][6] - The response from European facility management companies was notably positive, indicating strong interest in integrating autonomous cleaning solutions [8]
Kulicke & Soffa Schedules Second Quarter 2025 Conference Call for 8:00 AM ET, May 7th, 2025
Prnewswire· 2025-04-22 13:05
Core Viewpoint - Kulicke and Soffa Industries, Inc. is set to announce its second fiscal quarter 2025 financial results on May 6, 2025, with a conference call scheduled for May 7, 2025, to discuss these results and the company's business outlook [1][2]. Group 1: Financial Results Announcement - The company will release its second fiscal quarter 2025 financial results on the evening of May 6, 2025, at approximately 4:00 pm ET [2]. - A conference call to discuss the financial results and business outlook is scheduled for May 7, 2025, at 8:00 am ET [1]. Group 2: Accessing the Conference Call - Interested parties can access the conference call by calling +1-877-407-8037 or internationally +1-201-689-8037 [2]. - A live webcast and replay of the conference call will be available at investor.kns.com [2]. Group 3: Replay Information - A replay of the conference call will be available approximately one hour after the call's completion until May 14, 2025, by calling +1-877-660-6853 or internationally +1-201-612-7415, using the replay ID number 13750874 [3]. Group 4: Company Overview - Kulicke and Soffa is a global leader in semiconductor assembly technology, focusing on enhancing device performance across various markets including automotive, compute, industrial, memory, and communications [4]. - Founded in 1951, the company is positioned to address dynamic process challenges and create long-term value by aligning technology with market opportunities [4].
Akari Therapeutics Releases Welcome Video from Newly Appointed Chief Executive Officer, Abizer Gaslightwala
GlobeNewswire· 2025-04-22 13:05
For more information about the Company, please visit www.akaritx.com and connect on X and LinkedIn. Cautionary Note Regarding Forward-Looking Statements Biotechnology and pharmaceutical industry veteran, Abizer Gaslightwala, shares his vision for Akari moving forward Access the video here BOSTON and LONDON, April 22, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing next-generation precision bi-functional antibody drug conjugates (ADC) for the treatment of c ...
illumin Holdings Inc. Announces Date for First Quarter 2025 Financial and Operating Results
GlobeNewswire· 2025-04-22 13:05
Core Viewpoint - illumin Holdings Inc. will report its first quarter 2025 financial results on May 9, 2025, before market open, highlighting its position in the digital advertising technology sector [1]. Group 1: Financial Reporting - The company is set to announce its Q1 2025 financial results on May 9, 2025, before the market opens [1]. - A live webcast will be held on the same day at 8:30 AM ET, featuring CEO Simon Cairns and CFO Elliot Muchnik discussing the results [2]. Group 2: Conference Call Details - Investors and analysts can register for the conference call webcast through the provided link, with a recommendation to connect 15 minutes early for any necessary software downloads [3]. - A recording of the conference call will be available on the company's website after the event [3]. Group 3: Company Overview - illumin is focused on transforming the digital advertising landscape by enabling marketers to achieve significant results through a customer-centric approach [4]. - The company offers a unified platform that integrates various marketing channels, including programmatic, email, and social media, facilitating seamless campaign execution [4]. - Headquartered in Toronto, Canada, illumin serves clients across North America, Latin America, and Europe [4].
Davos Alzheimer’s Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer’s Disease Research in North Africa
GlobeNewswire· 2025-04-22 13:05
Core Viewpoint - The Davos Alzheimer's Collaborative (DAC) is launching the North African Dementia Registry (NADR) project in collaboration with PacBio, The American University in Cairo (AUC), and UCL to enhance understanding of Alzheimer's disease and dementia in diverse populations, particularly in North Africa [1][2][3] Group 1: Project Overview - The NADR is the first dementia-focused registry in North Africa, aiming to collect biosamples, conduct cognitive assessments, and perform digital phenotyping [2] - The initiative will create a comprehensive multi-omics dataset to explore genetic and environmental factors related to Alzheimer's disease [2][3] - Data generated will be accessible via the Alzheimer's Disease Data Initiative (ADDI) platform, promoting global research collaboration [3] Group 2: Technological Partnership - PacBio will provide its advanced long-read sequencing technology to generate high-quality genomic data essential for understanding the genetic landscape of Alzheimer's disease [2][3] - The collaboration aims to identify new diagnostic tools and therapeutic solutions for Alzheimer's disease [3] Group 3: Importance of Diversity in Research - The project addresses the underrepresentation of North African populations in dementia research, which is crucial given the region's genetic diversity [2][3] - Insights gained from this research are expected to inform locally relevant prevention and intervention strategies [3] Group 4: Broader Implications - DAC aims to extend global research efforts beyond traditional Western populations to include diverse populations in the Global South, where most Alzheimer's patients reside [4] - The initiative aligns with DAC's goal to implement health system solutions that are globally applicable and to promote brain health throughout the lifespan [4][5]
Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa
Newsfilter· 2025-04-22 13:04
Core Insights - The Davos Alzheimer's Collaborative (DAC) has partnered with PacBio to support the North African Dementia Registry (NADR) project, aiming to enhance understanding of Alzheimer's disease in North African populations [1][2][3] - This initiative is the first dementia-focused registry in North Africa, addressing the underrepresentation of these populations in dementia research [2][3] - The collaboration will utilize PacBio's long-read sequencing technology to create a comprehensive multi-omics dataset, facilitating research into genetic and environmental factors related to Alzheimer's disease [2][3] Company Insights - PacBio is recognized for its advanced sequencing solutions, which are crucial for generating high-quality genomic data necessary for understanding the complex genetic landscape of Alzheimer's disease [3][12] - The partnership aligns with PacBio's commitment to enabling genomic discoveries that improve human health globally [3][12] - The data generated from this collaboration will be accessible through the Alzheimer's Disease Data Initiative (ADDI) platform, promoting further research and innovation in Alzheimer's disease [3][4] Industry Insights - The DAC initiative aims to extend global research efforts beyond traditional Western populations to include diverse populations in the Global South, where a significant number of Alzheimer's cases exist [4] - By 2050, it is projected that over 150 million families and half a billion people will be affected by dementia, highlighting the urgent need for effective research and intervention strategies [4] - The NADR project will enable the collection of biosamples, cognitive assessments, and digital phenotyping, which are essential for developing locally relevant prevention and intervention strategies [2][3]